Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy

Journal of Nuclear Medicine

Volumn 43, Issue 4, 2002, Pages 500-509

  Mankoff, David A ^a   Dunnwald, Lisa K ^a   Gralow, Julie R ^a   Ellis, Georgiana K ^a   Charlop, Aaron ^a   Lawton, Thomas J ^a   Schubert, Erin K ^a   Tseng, Jeffrey ^a   Livingston, Robert B ^a  

^a Division of Nuclear Medicine   (United States)

Author keywords

15O water; 18F FDG; Breast cancer; Neoadjuvant chemotherapy; PET; Response to therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; PACLITAXEL; TRASTUZUMAB; WATER O 15;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GLUCOSE METABOLISM; HUMAN; MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BLOOD FLOW;

ADULT; AGED; BLOOD FLOW VELOCITY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MIDDLE AGED; OXYGEN RADIOISOTOPES; PROGNOSIS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0036218516     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Staging of cancer
2. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
3. Comprehensive management of locally advanced breast cancer
4. Treatment of locally advanced breast cancer
5. Pathological assessment of response to induction chemotherapy in breast cancer
6. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma
7. Assessment of the new proliferation marker MIBI in breast carcinoma using image analysis: Associations with other prognostic factors and survival
8. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays
9. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
10. Antitumor treatment: Tumor blood flow - Measurement and manipulation for therapeutic gain
11. Haemodynamic and transport barriers to the treatment of solid tumors
12. Technetium-99m sestamibi: An indicator of breast cancer invasiveness
13. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: A rapid and non-invasive dynamic method
14. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging
15. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy
16. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma
17. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium-99m]-sestamibi scintimammography
18. Breast carcinoma: Measurement of tumor response to primary medical therapy with color flow Doppler imaging
19. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
20. Hypoxia and drug resistance
21. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation
22. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer
23. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: A method for early therapy evaluation?
24. 18F]-D-glucose
25. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
26. Investigation of the count rate performance of the General Electric ADVANCE positron emission tomograph
27. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
28. Validation of PET-acquired input functions for cardiac studies
29. Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data
30. Assessment of response to therapy in advanced breast cancer
31. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose
32. Tumor hypoxia and gene expression
33. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
34. L prevents the initial disease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis
35. FDG PET measurement of the proliferative potential of non-small cell lung cancer
36. Lung cancer proliferation correlates with FDG uptake by PET
37. Analysis of the deoxyglucose lumped constant in human malignant gliomas
38. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy